Search

Your search keyword '"F. Milord"' showing total 93 results

Search Constraints

Start Over You searched for: Author "F. Milord" Remove constraint Author: "F. Milord"
93 results on '"F. Milord"'

Search Results

4. The changing landscape of travel health services in Canada

5. Travel‐Related Shigellosis in Quebec, Canada: An Analysis of Risk Factors

6. Cases of Malaria, Hepatitis A, and Typhoid Fever Among VFRs, Quebec (Canada)

7. Cyclospora cayetanensis: a description of clinical aspects of an outbreak in Quebec, Canada

9. Immunogenicity and feasibility of intradermal vaccination against rabies in Quebec

10. The Impact of Syphilis, HIV-1, and HIV-2 on Pregnancy Outcome in Bissau, Guinea-Bissau

11. Epidemiological evidence for immunity following Trypanosoma brucei gambiense sleeping sickness

12. Risk factors for encephalopathy and mortality during melarsoprol treatment of Trypanosoma brucei gambiense sleeping sickness

13. Investigations of foodborne outbreaks caused by a parasite in Canada

14. Contributor contact details

15. Gambiense trypanosomiasis: frequency of, and risk factors for, failure of melarsoprol therapy

16. Eflornithine concentrations in serum and cerebrospinal fluid of 63 patients treated for Trypanosoma brucei gambiense sleeping sickness

17. The Indian Ocean paradox revisited: HIV and sexually transmitted infections in the Comoros

18. Evaluation of the rubella surveillance system in Quebec

19. First known outbreak of colonizing vancomycin-resistant enterococci in Quebec

20. Hepatitis A in restaurant clientele and staff--Quebec

22. The treatment of human African trypanosomiasis

23. Efficacy and toxicity of eflornithine for treatment of Trypanosoma brucei gambiense sleeping sickness

24. High-dose nifurtimox for arseno-resistant Trypanosoma brucei gambiense sleeping sickness: an open trial in central Zaire

25. African trypanosomiasis and drug-induced encephalopathy: risk factors and pathogenesis

26. TRIAL OF PREDNISOLONE FOR PREVENTION OF MELARSOPROL-INDUCED ENCEPHALOPATHY IN GAMBIENSE SLEEPING SICKNESS

27. An open clinical trial of nifurtimox for arseno-resistant Trypanosoma brucei gambiense sleeping sickness in central Zaire

29. [The use of difluoromethylornithine in congenital trypanosomiasis due to Trypanosoma brucei-gambiense]

30. Difluoromethylornithine for arseno-resistant Trypanosoma brucei gambiense sleeping sickness

31. [Integration of African human trypanosomiasis control in a network of multipurpose health centers]

32. Self-reported tick exposure as an indicator of Lyme disease risk in an endemic region of Quebec, Canada.

33. Current and future burden from Lyme disease in Québec as a result of climate change.

34. Integrated human behavior and tick risk maps to prioritize Lyme disease interventions using a 'One Health' approach.

35. Quality over quantity in active tick surveillance: Sentinel surveillance outperforms risk-based surveillance for tracking tick-borne disease emergence in southern Canada.

36. Criteria for selecting sentinel unit locations in a surveillance system for vector-borne disease: A decision tool.

37. An ecological approach to predict areas with established populations of Ixodes scapularis in Quebec, Canada.

38. Environmental Investigation during Legionellosis Outbreak, Montérégie, Quebec, Canada, 2021.

39. Management and clinical outcomes of Lyme disease in acute care facilities in 2 endemic regions of Quebec, Canada: a multicentre retrospective cohort study.

40. Sentinel Surveillance Contributes to Tracking Lyme Disease Spatiotemporal Risk Trends in Southern Quebec, Canada.

41. Behavioral risk factors associated with reported tick exposure in a Lyme disease high incidence region in Canada.

42. Economic Burden of West Nile Virus Disease, Quebec, Canada, 2012-2013.

43. Evidence for increasing densities and geographic ranges of tick species of public health significance other than Ixodes scapularis in Québec, Canada.

44. Passive Tick Surveillance Provides an Accurate Early Signal of Emerging Lyme Disease Risk and Human Cases in Southern Canada.

45. The changing landscape of travel health services in Canada.

46. Morbidity, mortality and long-term sequelae of West Nile virus disease in Québec.

47. Integrated Social-Behavioral and Ecological Risk Maps to Prioritize Local Public Health Responses to Lyme Disease.

48. Practices of Lyme disease diagnosis and treatment by general practitioners in Quebec, 2008-2015.

49. Acceptability of tick control interventions to prevent Lyme disease in Switzerland and Canada: a mixed-method study.

50. Adaptation and Evaluation of a Multi-Criteria Decision Analysis Model for Lyme Disease Prevention.

Catalog

Books, media, physical & digital resources